Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Found vs GoodRx

Found and GoodRx both sell tirzepatide and orforglipron; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Found logo

Found

8.6
★★★★☆4.3/5

Best for: tirzepatide at $169/month, 37% below the typical price

Visit Found →
VS
GoodRx logo

GoodRx

6.9
★★★★☆3.5/5

Best for: oral orforglipron alongside the injectables

Visit GoodRx →

If you are choosing between Found and GoodRx, price alone will not settle it. Both prescribe tirzepatide and orforglipron, so moving from one to the other would not change your drug. Found leads our six-part score, 8.6 to 6.9.

Found vs GoodRx price

Found and GoodRx start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Tirzepatide is cheaper at Found ($169 a month vs $299 a month); orforglipron costs the same at both, $149 a month.

Medications and formats

Both sell tirzepatide and orforglipron; only Found lists semaglutide.

On format, Found prices compounded injections, an oral option and brand-name pens, while GoodRx prices brand-name pens.

Where each one treats patients

Found lists 50 states, and GoodRx lists 50 states.

They overlap in 50 states.

Pricing

Found

flat price at every doseCompounded
$169$99/mo
Save 41% right now
semaglutide

$169/mo cash-pay on the 12-month prepaid plan, with medication, membership and coaching included; $99/mo with insurance on the same 12-month prepaid plan. Month-to-month: $199/mo with insurance, $289/mo cash. A '$100 off today' promo was running at checkout.

flat price at every doseCompounded
$169$99/mo
Save 41% right now
tirzepatide

Same Compounded GLP-1 Plan price as semaglutide, with no per-drug price published; the drug and price are set after intake. Cash: $169/mo prepaid for 12 months or $289/mo month to month. Insurance: $99/mo prepaid.

StartingCompounded · oral
$149/mo
orforglipron (foundayo)

Starting cash price of about $149/mo, listed on Found's Foundayo comparison table. Newly added to Found's menu.

StartingBrand-name
$650/mo
semaglutide (wegovy)

Homepage carousel 'Wegovy® from $650/mo+'; but /medication/foundayo table lists 'Wegovy® Pen ... Starting cash price ~$199/mo' — internally inconsistent on their own site.

StartingBrand-name
$650/mo
tirzepatide (zepbound)

Homepage carousel 'Zepbound® from $650/mo+'; /medication/foundayo table shows Zepbound ~$299/mo starting cash price.

StartingBrand-name
$1100/mo
semaglutide (ozempic)

Brand-name Ozempic at $1,100/mo, as advertised on the homepage.

StartingBrand-name
$1100/mo
tirzepatide (mounjaro)

Homepage carousel 'Mounjaro® ~$1100/mo' — unchanged. Non-GLP-1 generics plan from $49/mo; microdosing program price not published.

GoodRx

Foundayo (lowest dose, self-pay)Brand-name
$149/mo
orforglipron
Zepbound KwikPen (self-pay)Brand-name
$299/mo
tirzepatide

What each price covers

Found's price also covers the clinician visit, the medication itself and coaching, which GoodRx does not claim.

Found is silent on shipping and lab work.

GoodRx does not say what its price includes.

That matters most for the drug: unless GoodRx confirms otherwise, budget for medication on top of its listed price.

Found

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

Not stated

Lab work

Not stated

Coaching

In the price

GoodRx

Inclusions not disclosed.

Where each one scores higher

Overall, Found scores 8.6 and GoodRx 6.9 out of 10.

Found is stronger on value (7.8 vs 5.0), user experience (8.0 vs 5.0), trust & safety (8.5 vs 6.0) and support (7.0 vs 5.0).

Effectiveness and accessibility are within half a point.

How we score

Found

8.6/10

Overall

GoodRx

6.9/10

Value25%

7.8A
vs
B
5.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
5.0

Trust & Safety15%

8.5A
vs
B
6.0

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
5.0

FDA warning letters

Neither Found nor GoodRx has an FDA warning letter on record with us.

Features & Coverage

FeatureFoundGoodRx
Starting Price$149/mo$149/mo
Features3 features✓6 features
States Available5050
Compounded✓ Yes—
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Found

Found is a personalized weight care platform. It runs on a self-pay membership, and medication costs sit on top of that.

Read our full Found review →

About GoodRx

GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.

Read our full GoodRx review →

Pros & Cons

Found

What we like

  • Tirzepatide costs $169 a month, 32% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and coaching
  • Serves all 50 states
  • We found no FDA warning letters issued to Found

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its orforglipron, semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

GoodRx

What we like

  • Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
  • Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
  • Serves all 50 states
  • We found no FDA warning letters issued to GoodRx

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Our Verdict

Winner: Found

Found wins this one, 8.6 to 6.9, above all for tirzepatide at $169/month, 37% below the typical price. GoodRx fits better if oral orforglipron alongside the injectables is your priority.

Choose Found if…

You want tirzepatide at $169/month, 37% below the typical price and an opening price near $149 a month.

Choose GoodRx if…

You want oral orforglipron alongside the injectables and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.3

RNK Health

An oral route if you will not self-inject

9.2

He & She MD

Starting below a standard dose, with microdose tiers

5.9

Wellorithm

Compounded semaglutide at $247/month

Found vs GoodRx: FAQ

Neither on the entry price: Found and GoodRx both start at about $149 a month. The difference is in what the price includes.
Yes, both sell tirzepatide and orforglipron. Found adds semaglutide.
Both list 50 states and share 50.
Only Found includes the clinician visit, the medication itself and coaching.
Found has none. GoodRx has none.
Found pays us a commission on sign-ups through our links; GoodRx does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.